by William Jester | May 30, 2020 | Community, News
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That’s when most drugs get price tags. Gilead Sciences, which makes...
by William Jester | May 30, 2020 | Community, News
Rutgers has launched a clinical trial to test the safety and efficacy of an oral anti-inflammatory drug that could help prevent serious illness and death in early-stage COVID-19 patients. The drug, EDP1815, developed by Evelo Biosciences Inc., will be given to newly...
by William Jester | May 29, 2020 | Community
Website created to house resources for parents with children struggling with behavior at home. Got a kindergartener who refuses to practice their sight words? An out-of-sorts elementary schooler who’s experiencing nightmares? A middle schooler whose math teacher just...
by William Jester | May 29, 2020 | Community, News
The Rutgers Institute for Health, Health Care Policy and Aging Research has launched a social media campaign to provide New Jersey’s minority and immigrant communities with information and resources they need to stay informed in their own languages about COVID-19....
by William Jester | May 28, 2020 | Community, News
The New Jersey Legislature postponed a final vote last year on a vaccine bill that would have put an end to religious exemptions from vaccinations for all students enrolled in public and private schools and colleges statewide. The vote occurred against a backdrop of...
